Results 81 to 90 of about 3,528 (147)

Self‐Reported Adverse Events Following COVID‐19 Vaccination Among Medical Sciences Students After a Symptomatology Training Program: A Cross‐Sectional Study

Health Science Reports, Volume 8, Issue 3, March 2025.
ABSTRACT Background and Aims Accurate and transparent investigation of adverse events (AEs) following COVID‐19 vaccination enhances social trust and confidence in vaccination programs. This study aimed to assess the prevalence of COVID‐19 vaccination‐related AEs among medical sciences students. Methods In this cross‐sectional study, a self‐administered
Taraneh Tavanaei Tamanaei, Mohammad Bagher Oghazian, Mehran Mojtabaee, Mojdeh Faregh, Sahar Oghazian, Erfan Tavana, Amin Hoseinzadeh, Ramin Haghighi   +7 more
wiley   +1 more source

Anti-Spike IgG geometric mean titer (GMT), mean rise, fold rise, and fourfold rise rate between ChAdOx1-S and BBIBP-CorV homologous and heterologous groups.

, 2023
Anti-Spike IgG geometric mean titer (GMT), mean rise, fold rise, and fourfold rise rate between ChAdOx1-S and BBIBP-CorV homologous and heterologous groups.
Carmen Valenzuela Silva (17319206), Amitis Ramezani (6329339), Alireza Biglari (12152590), Sana Eybpoosh (2826068), Anahita Bavand (6329345), Mostafa Salehi-Vaziri (6273803), Mohammad Banifazl (17319212), Sarah Dahmardeh (17319209), Vicente Verez-Bencomo (17319200), Rahim Sorouri (17319194), Maria Eugenia Toledo-Romani (17319203), Ehsan Mostafavi (406077), Mona Sadat Larijani (17319197), Delaram Doroud (348344), Fatemeh Ashrafian (9619876)   +14 more
core   +1 more source

The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions

The FEBS Journal, Volume 292, Issue 6, Page 1480-1499, March 2025.
Vaccination plays a crucial role in mediating protection against infectious diseases, but immune responses to vaccination are highly variable and frequently sub‐optimal in vulnerable populations. Here, we review the latest preclinical and clinical evidence demonstrating that the gut microbiota plays a significant role in regulating immune responses to ...
Charné Rossouw, Feargal J. Ryan, David J. Lynn   +2 more
wiley   +1 more source

Dynamic Changes and Trends of SARS‐CoV‐2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points

Journal of Medical Virology, Volume 97, Issue 1, January 2025.
ABSTRACT As the COVID‐19 pandemic continues, increasingly complex vaccination and infection histories have made it urgent to investigate the antibody dynamics in populations with hybrid immunity. This study aimed to explore the multi‐time‐point dynamics of SARS‐CoV‐2 IgG antibody levels in a community‐based population in Jiangsu Province, China ...
Shihan Zhang, Xiaoxiao Kong, Qian Zhen, Ye Wei, Chao Shi, Songning Ding, Liling Chen, Chen Dong, Hua Tian, Chuchu Li, Lu Zhou, Yazhen Zhang, Fengcai Zhu, Jianli Hu, Changjun Bao, Hui Jin, Ke Xu, Liguo Zhu   +17 more
wiley   +1 more source

Association of age and history of COVID-19 infection with mean rise and seroconversion rate of anti-spike IgG antibodies between the BBIBP-CorV -primed groups.

, 2023
Association of age and history of COVID-19 infection with mean rise and seroconversion rate of anti-spike IgG antibodies between the BBIBP-CorV -primed groups.
Carmen Valenzuela Silva (17319206), Amitis Ramezani (6329339), Alireza Biglari (12152590), Sana Eybpoosh (2826068), Anahita Bavand (6329345), Mostafa Salehi-Vaziri (6273803), Mohammad Banifazl (17319212), Sarah Dahmardeh (17319209), Vicente Verez-Bencomo (17319200), Rahim Sorouri (17319194), Maria Eugenia Toledo-Romani (17319203), Ehsan Mostafavi (406077), Mona Sadat Larijani (17319197), Delaram Doroud (348344), Fatemeh Ashrafian (9619876)   +14 more
core   +1 more source

Oral Immunisation With Non‐GMO Surface Displayed SARS‐CoV‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice

Microbial Biotechnology, Volume 18, Issue 1, January 2025.
Mucosal vaccines using food‐grade bacteria, such as lactic acid bacteria, are promising strategies for developing effective vaccines against SARS‐CoV‐2. In this study, we designed a non‐GMO surface‐displayed SARS‐CoV‐2 spike S1 epitope on Limosilactobacillus fermentum‐derived BLP.
Robie Vasquez, Ji Hoon Song, Remilyn M. Mendoza, In‐Chan Hwang, Bernadette B. Bagon, Lars Engstrand, Valerie Diane Valeriano, Dae‐Kyung Kang   +7 more
wiley   +1 more source

Estimates Vaccine effectiveness of inactivated vaccine BBIBP-CorV against COVID-19-associated severe or critical hospitalization according to age and gender over time since second dose vaccination.

, 2022
Estimates Vaccine effectiveness of inactivated vaccine BBIBP-CorV against COVID-19-associated severe or critical hospitalization according to age and gender over time since second dose vaccination.
Redouane Abouqal (51120), Majdouline Obtel (14232315), Rachid Razine (3229083), Jihane Belayachi (51116), Abdelkader Mhayi (14232318)   +4 more
core   +1 more source

The Effectiveness and Influence of COVID‐19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta‐Analysis

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2025, Issue 1, 2025.
Background: The COVID‐19 pandemic has disproportionately affected pregnant individuals, increasing risks of severe illness and adverse outcomes. While vaccination is a key mitigation strategy, initial exclusion from clinical trials led to limited safety data. Despite evidence of vaccine effectiveness, hesitancy persists in this population.
Zi-Jin Lei, Min-Xi Bai, Min-Jue Li, Peng Jin, Yu-Bin Ding, Timotius Ivan Hariyanto   +5 more
wiley   +1 more source

A Systematic Review of Ocular Complications Following Different Types of Covid‐19 Vaccines

Journal of Immunology Research, Volume 2025, Issue 1, 2025.
Introduction More than 6 million deaths from the novel coronavirus, the Coronavirus disease 2019 (COVID‐19) infection, have prompted the development of several prophylactic vaccines of COVID‐19. This systematic review summarizes the ocular complications of various COVID‐19 vaccinations, diseases diagnosed, treatment, and risk factors.
Bahareh Ebrahimi, Hossein Kargar Jahromi, Nazanin Shafiei Jahromi, Mina Molayem, Poorani Gurumallesh   +4 more
wiley   +1 more source

Immunogenicity of two‐dose sinopharm BBIB‐CorV vaccine in Morocco: One‐year follow‐up and neutralizing activity against severe acute respiratory syndrome coronavirus 2 variants of concern

Immunity, Inflammation and Disease, Volume 12, Issue 11, November 2024.
This study assessed the immune response to the Sinopharm BBIB‐CorV vaccine against SARS‐CoV‐2 over a period of 1 year, using a two‐dose regimen. Conducted at the Military Hospital of Rabat, Morocco, the study found that additional booster vaccinations may be necessary based on the observed immunogenicity against various virus variants.
Maha Ouarab, Elarbi Bouaiti, Zineb Rhazzar, Hicham El Annaz, Safae el kochri, Mouhssine Hemlali, Hamza Ghammaz, Omar Nyabi, Karim el Bakkouri, Nadia Touil, Mostafa Elouennass, Lamiae Belayachi, Jean Luc Gala, Khalid Ennibi, Elmostafa El Fahime   +14 more
wiley   +1 more source